Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExPERT: Amlodipine/Valsartan Morning vs Evening Intake in Hypertension
NCT00700271Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of amlodipine, valsartan in hypertension (HTN), sponsored by Novartis. Started Oct 2007; status: completed.
02
Drugs
amlodipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00700271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700271.